Nuveen Asset Management, LLC Trevena Inc Transaction History

Nuveen Asset Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.2 - $0.5 $102,853 - $257,134	-514,269 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$0.57 - $1.29 $33,922 - $76,773	-59,514 Reduced 10.37%	514,269 $341,000
Q3 2021 Nov 12, 2021	BUY	$1.11 - $1.7 $9,416 - $14,421	8,483 Added 1.5%	573,783 $781,000
Q2 2021 Aug 16, 2021	BUY	$1.46 - $2.25 $825,338 - $1.27 Million	565,300 New	565,300 $956,000

Ticker TRVN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 173,680,992
Market Cap $273M
Description
Trevena, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel medicines for patients affected by central nervous system disorders. Its lead product candidates include OLINVYK (Oliceridine) injection, a G protein biased mu-opioid receptor (MOR) ligand for the management of moderate-to-severe acute pain; TRV...

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Nuveen Asset Management, LLC with notifications on news.